Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-01-27 @ 6:22 AM
Study NCT ID:
NCT01555268
Status:
COMPLETED
Last Update Posted:
2022-09-13
First Post:
2012-02-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Sponsor:
Roswell Park Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adult Acute Megakaryoblastic Leukemia (M7) | View |
| None | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | View |
| None | Adult Acute Monoblastic Leukemia (M5a) | View |
| None | Adult Acute Monocytic Leukemia (M5b) | View |
| None | Adult Acute Myeloblastic Leukemia With Maturation (M2) | View |
| None | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | View |
| None | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | View |
| None | Adult Acute Myeloid Leukemia With Del(5q) | View |
| None | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | View |
| None | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | View |
| None | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | View |
| None | Adult Acute Myelomonocytic Leukemia (M4) | View |
| None | Adult Erythroleukemia (M6a) | View |
| None | Adult Pure Erythroid Leukemia (M6b) | View |
| None | Recurrent Adult Acute Myeloid Leukemia | View |
| None | Untreated Adult Acute Myeloid Leukemia | View |
Keywords: